Diasorin
DiaSorin Ireland (formerly Biotrin International) has a history of developing niche Immuno Assays, some of which became best-in-class worldwide from both a quality and commercial standpoint.
DiaSorin Ireland's core competencies lie in Product Development, Regulatory compliance, high quality and reliable Manufacturing. These skills are currently being applied to Molecular Diagnostic Product Development and Manufacturing.
Financial Data
-
31st Dec 17 Source: CRO
- €18.7 million turnover
-
-€4.6 million
profit - 69 employees
-
31st Dec 16 Source: CRO
- €19 million turnover
-
€3.5 million
profit - 73 employees
- 2 more years available »
Ranking
By Turnover
(€18.7 million)- 897th in Top Companies
- 97th in Health
By Employees
(69)- 782nd in Top Companies
- 90th in Health
- 69
- €18.7 million
Employees
- John Eskdale Country Manager
Latest News
- 5:13am Ireland approached to back Mark Carney as next IMF boss
- 5:00am DIT facility sold for over €5.5m to tourist accommodation provider
- 4:45am Fully-let Georgian investment in Dublin 2 guiding at €995,000
- 4:30am Dublin industrial investments offer investors net initial yields of up to 8.8%
- 3:45am Office block at heart of Dublin’s legal quarter guiding at €775,000